Carbon-ion radiotherapy achieves outcomes equivalent to surgical resection for hepatocellular carcinoma.

16 Although the addition of SBRT showed a clinically meaningful improvement over sorafenib alone, the difference did not reach statistical significance. 16 Notably, approximately 70% of patients in this trial had MVI, suggesting that SBRT may be particularly beneficial in this subgroup.

also in 111,027 other papers